Showing results (81-90 of 249) with videos related to

Sort By:
Pageof 25
Cancer Immunology, Immunotherapy : CII|October 2, 2008
The immunodominant HLA-A2-restricted MART-1 epitope is not presented on the surface of many melanoma cell linesRikke Baek Sørensen, Niels Junker, Alexei Kirkin, et al.
The Journal of Investigative Dermatology|September 28, 2012
Methods to improve adoptive T-cell therapy for melanoma: IFN-γ enhances anticancer responses of cell products for infusionMarco Donia, Morten Hansen, Sarah L Sendrup, et al.
Oncoimmunology|May 12, 2015
Spontaneous presence of FOXO3-specific T cells in cancer patientsStine Kiaer Larsen, Shamaila Munir Ahmad, Manja Idorn, et al.
Blood|September 16, 2004
Immunogenicity of Bcl-2 in patients with cancerMads Hald Andersen, Inge Marie Svane, Pia Kvistborg, et al.
Oncoimmunology|April 11, 2018
Improved migration of tumor ascites lymphocytes to ovarian cancer microenvironment by CXCR2 transductionManja Idorn, Maria Olsen, Hólmfrídur Rósa Halldórsdóttir, et al.
Cancer Immunology, Immunotherapy : CII|April 10, 2015
Broadening the repertoire of melanoma-associated T-cell epitopesThomas Mørch Frøsig, Rikke Lyngaa, Özcan Met, et al.
The Journal of Investigative Dermatology|March 29, 2002
Differential expression of inhibitory or activating CD94/NKG2 subtypes on MART-1-reactive T cells in vitiligo versus melanoma: a case reportLars Østergaard Pedersen, Claudia S Vetter, Maria C Mingari, et al.
Biomarker Research|December 19, 2024
AXL in myeloid malignancies - an elusive target?Pia Aehnlich, Katharina Leuchte, Claudia Schöllkopf, et al.
Cancer Immunology, Immunotherapy : CII|December 8, 2004
Spontaneous T-cell responses against peptides derived from the Taxol resistance-associated gene-3 (TRAG-3) protein in cancer patientsAnders Meier, Sine Reker, Inge Marie Svane, et al.
Vaccine|December 4, 2012
Comparison of clinical grade type 1 polarized and standard matured dendritic cells for cancer immunotherapyMorten Hansen, Gertrud Malene Hjortø, Marco Donia, et al.
Pageof 25